Blood‐Based Clinical Markers for Early Dementia Detection: Insights from AD‐DETECT‐Cohort
Our findings demonstrated the potential of HDL and FT4 as blood-based clinical markers for early detection of cognitive impairment and dementia.
Authors
- Samuel Nguku
- Levi A. Muyela
- Rachel Maina (ORCID: https://orcid.org/0000-0002-6038-1357)
- Anne Njogu (ORCID: https://orcid.org/0000-0003-0333-3380)
- Karen Blackmon (ORCID: https://orcid.org/0000-0002-2665-7807)
- Jasmit Shah (ORCID: https://orcid.org/0000-0002-7957-5426)
- Dilraj Sokhi (ORCID: https://orcid.org/0000-0002-8819-0851)
- Juzar Hooker (ORCID: https://orcid.org/0000-0001-7057-1843)
- Sheila Waa
- Zul Merali (ORCID: https://orcid.org/0000-0002-6360-7913)
- Benard Aliwa
- Harrison Kaleli
- Litha Musili
- Anne Njoki Gitere
- Olivera Nesic‐Taylor
- Sylvia Mbugua
- Chinedu T Udeh‐Momoh
Institutions
- Dartmouth College (US)
- Dartmouth–Hitchcock Medical Center (US)
- Public Health Agency of Sweden (SE)
- Aga Khan University Hospital Nairobi (KE)
- Aga Khan University Nairobi (KE)
- Global Brain Health Institute (US)
- Wake Forest University (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_103368
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00